Can research at the end of life be a useful tool to advance HIV cure?
- PMID: 27755112
- PMCID: PMC5137789
- DOI: 10.1097/QAD.0000000000001300
Can research at the end of life be a useful tool to advance HIV cure?
Abstract
Despite extensive investigations, we still do not fully understand the dynamics of the total body HIV reservoir and how sub-reservoirs in various compartments relate to one another. Studies using macaque models are enlightening but eradication strategies will still need to be tested in humans. To take the next steps in understanding and eradicating HIV reservoirs throughout the body, we propose to develop a “peri-mortem translational research model” of HIV-infected individuals (called ‘The Last Gift’), which is similar to existing models in cancer research. In this model, altruistic, motivated HIV-infected individuals with advanced non-AIDS related diseases and with six months or less to live will participate in HIV cure research and donate their full body after they die. Engaging this population provides a unique opportunity to compare the HIV reservoir before and after death across multiple anatomic compartments in relation to antiretroviral therapy use and other relevant clinical factors. Furthermore, people living with HIV/AIDS at the end of their lives may be willing to participate to cure interventions and accept greater risks for research participation. A broad, frank, and pragmatic discussion about performing HIV cure research near the end of life is necessary.
Conflict of interest statement
Authors do not have any commercial or other associations that might pose a conflict of interest.
Similar articles
-
Pharmacoresistance: an emerging clinical problem.J Biol Regul Homeost Agents. 1998;12(1-2 Suppl):9-14. J Biol Regul Homeost Agents. 1998. PMID: 9689572 Review. No abstract available.
-
Ongoing HIV dissemination during HAART.Nat Med. 1999 Oct;5(10):1099-104. doi: 10.1038/13410. Nat Med. 1999. PMID: 10502799 No abstract available.
-
HIV/AIDS research. Tissue says blood is misleading, confusing HIV cure efforts.Science. 2011 Dec 23;334(6063):1614. doi: 10.1126/science.334.6063.1614. Science. 2011. PMID: 22194536 No abstract available.
-
The challenge of finding a cure for HIV infection.Science. 2009 Mar 6;323(5919):1304-7. doi: 10.1126/science.1165706. Science. 2009. PMID: 19265012 Review.
-
[Campaign against a chameleon. Therapeutic strategies to control a survival artist].MMW Fortschr Med. 2000 Mar 13;142 Suppl 1:80-1. MMW Fortschr Med. 2000. PMID: 10863320 German. No abstract available.
Cited by
-
"My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life.AIDS Res Hum Retroviruses. 2020 Dec;36(12):1071-1082. doi: 10.1089/AID.2020.0020. Epub 2020 Jun 24. AIDS Res Hum Retroviruses. 2020. PMID: 32449625 Free PMC article.
-
Willingness to participate in HIV research at the end of life (EOL).PLoS One. 2018 Jul 23;13(7):e0199670. doi: 10.1371/journal.pone.0199670. eCollection 2018. PLoS One. 2018. PMID: 30036365 Free PMC article.
-
Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States.PLoS One. 2021 Jul 16;16(7):e0254148. doi: 10.1371/journal.pone.0254148. eCollection 2021. PLoS One. 2021. PMID: 34270612 Free PMC article.
-
HIV persists throughout deep tissues with repopulation from multiple anatomical sources.J Clin Invest. 2020 Apr 1;130(4):1699-1712. doi: 10.1172/JCI134815. J Clin Invest. 2020. PMID: 31910162 Free PMC article.
-
"[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life.PLoS One. 2020 Nov 18;15(11):e0242420. doi: 10.1371/journal.pone.0242420. eCollection 2020. PLoS One. 2020. PMID: 33206710 Free PMC article.
References
-
- Palella FJ, Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27–34. - PubMed
-
- Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278:1291–1295. - PubMed
-
- Svicher V, Ceccherini-Silberstein F, Antinori A, Aquaro S, Perno CF. Understanding HIV compartments and reservoirs. Curr HIV/AIDS Rep. 2014;11:186–194. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH105319/MH/NIMH NIH HHS/United States
- K24 AI100665/AI/NIAID NIH HHS/United States
- R01 MH094159/MH/NIMH NIH HHS/United States
- R01 MH101012/MH/NIMH NIH HHS/United States
- U24 MH100928/MH/NIMH NIH HHS/United States
- U01 AI043638/AI/NIAID NIH HHS/United States
- U01 AI068636/AI/NIAID NIH HHS/United States
- T32 AI007384/AI/NIAID NIH HHS/United States
- DP1 DA034978/DA/NIDA NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- P30 MH062512/MH/NIMH NIH HHS/United States
- P30 AI036214/AI/NIAID NIH HHS/United States
- R01 MH107345/MH/NIMH NIH HHS/United States
- UL1 TR000100/TR/NCATS NIH HHS/United States
- U19 AI096113/AI/NIAID NIH HHS/United States
- R01 MH097520/MH/NIMH NIH HHS/United States
- P01 AI074621/AI/NIAID NIH HHS/United States
- R01 MH100974/MH/NIMH NIH HHS/United States
- UM1 AI068636/AI/NIAID NIH HHS/United States
- R24 AI106039/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical